NewAmsterdam Pharma Co. NV (NAMS)
34.12
+1.13
(+3.43%)
USD |
NASDAQ |
Apr 06, 13:21
NewAmsterdam Pharma EPS Diluted (Quarterly) : -0.6549 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.5949 |
| ProQR Therapeutics NV | -0.1008 |
| argenx SE | -- |
| Pharming Group NV | 0.0699 |
| Pharvaris NV | -0.8343 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.92M |
| Revenue (Quarterly) | 0.032M |
| Total Expenses (Quarterly) | 74.96M |
| Enterprise Value | 3.156B |
| Gross Profit Margin (Quarterly) | -84.38% |
| Profit Margin (Quarterly) | -234.1K% |
| Earnings Yield | -5.12% |
| Normalized Earnings Yield | -4.793 |